AUPH Q1 2020 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30,000+0.0% YoY

Gross Profit

$30,000100.0% margin

Operating Income

-$27M-90200.0% margin

Net Income

-$26M-86440.0% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$315M

Total Liabilities

$52M

Stockholders' Equity

$263M

Cash & Equivalents

$274M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30,000	$30,000	+0.0%
Gross Profit	$30,000	-$11M	+100.3%
Operating Income	-$27M	-$15M	-81.8%
Net Income	-$26M	-$12M	-108.7%